In a clinical trial of HNSCC patients treated with neoadjuvant anti-PD1 therapy, it was shown that HPV-positive patients who did not respond to ICI therapy had elevated blood levels of IL-8. The gene discussed is CXCL8; the disease is head and neck squamous cell carcinoma.